SPP1 and myocardial infarction: Experimental studies have demonstrated that administration of anti-TLR2 antibodies (OPN-301 or OPN-305) reduced MI size when administered at the time of reperfusion, in both small and large animal AMI models (Arslan et al., 2010, Arslan et al., 2012).